This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Insilico Medicine IP Limited, Insilico Medicine Hong Kong Limited. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Andrey Kukharenko: Innovator in Kinase Inhibitors
Introduction
Andrey Kukharenko is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors for the treatment of various diseases. With a total of 3 patents to his name, Kukharenko is recognized for his innovative approaches to medical treatment.
Latest Patents
Kukharenko's latest patents focus on analogs for the treatment of disease. The disclosures provide TNIK and/or MAP4K4 kinases inhibitors aimed at treating various conditions. In one aspect, the patents describe kinase inhibitors with structures defined by Formula (A), (A*), (I), (IIA), or (IIB). Additionally, the patents detail pharmaceutical compositions that include these compounds and methods for their use. The methods outlined involve treating diseases or conditions by administering the described kinase inhibitors.
Career Highlights
Andrey Kukharenko is currently associated with Insilico Medicine IP Limited, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective treatments in the pharmaceutical industry.
Collaborations
Kukharenko collaborates with notable colleagues, including Aleksandrs Zavoronkovs and Aleksandr M Aliper. These partnerships enhance the innovative potential of his research and contribute to the advancement of medical science.
Conclusion
Andrey Kukharenko stands out as a key figure in the field of kinase inhibitors, with a focus on developing effective treatments for diseases. His contributions through patents and collaborations reflect his commitment to innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile